v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04937556 |
Full text link
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : April 21, 2022, 1 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : April 21, 2022, 1 a.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
2021-06-24 |
Recruitment status
Last imported at : June 1, 2022, 1:30 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - adult (18-65 years). - mild infection by sars-cov-2 detected by pcr or antigen. - onset of covid-19 symptoms up to 5 days before the day of inclusion - without hospitalization or oxygen supplementation on the day of inclusion. - signed written informed consent |
Exclusion criteria
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
- serious sars-cov-2 infection requiring hospitalization or oxygen supply - chronic diseases under regular medication (eg asthma, allergic rhinitis ...) - congenital or acquired immunodeficiency - body mass index (bmi)> 30 - coagulation disorders - short bowel syndrome or any surgery on the gastrointestinal tract. - metabolic disorders (diabetes, etc.). - heart failure and cardiac medical history - pregnant women. - hiv positive. - immunocompromised - history of significant gastrointestinal diseases - use of other probiotics during the last month. - uncertainty about the willingness or ability of the participant to comply with the requirements of the protocol. |
Number of arms
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
ProbiSearch SL |
Inclusion age min
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
65 |
Countries
Last imported at : Nov. 2, 2021, 12:30 p.m. Source : ClinicalTrials.gov |
Spain |
Type of patients
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
Severity scale
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
Total sample size
Last imported at : April 21, 2022, 1 a.m. Source : ClinicalTrials.gov |
41 |
primary outcome
Last imported at : July 21, 2021, 4 p.m. Source : ClinicalTrials.gov |
Concentration of specific IgM (Immunoglobulin M) and IgG (Immunoglobulin G) antibodies for the SARS-CoV-2 virus. |
Notes
Last imported at : June 26, 2021, 2 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : July 21, 2021, 4 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1598, "treatment_name": "Lactobacillus salivarius+vitamin d+zinc", "treatment_type": "Microbiota intervention+vitamins and dietary supplements", "pharmacological_treatment": "Non pharmacological treatment+pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |